Root Financial Partners »

Vertex Pharmaceuticals Incorporated shares owned by Root Financial Partners

Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by Root Financial Partners from 13F filings

Historical chart of Root Financial Partners investment in Vertex Pharmaceuticals Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Vertex Pharmaceuticals Incorporated held by Root Financial Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by Root Financial Partners

Quarter filed Position value Share count Share price at filing
2026-06-30 $236k 474 496.73
2026-03-31 $136k 305 446.54
2025-12-31 $122k 269 453.36
2025-09-30 $87k 223 391.64

More positions owned by Root Financial Partners

Dimensional U.s. Equity Market Etf Etf (DFUS)
Dimensional U.s. Small Cap Etf Etf (DFAS)
Dimensional International Core Equity Market Etf Etf (DFAI)
Dimensional Us Large Cap Value Etf Etf (DFLV)
Dimensional Short-duration Fixed Income Etf Etf (DFSD)
Dimensional Core Fixed Income Etf Etf (DFCF)
Dimensional Emerging Core Equity Market Etf Etf (DFAE)
Dimensional Ultrashort Fixed Income Etf Etf (DUSB)
Dimensional Us High Profitability Etf Etf (DUHP)
Dimensional International Value Etf Etf (DFIV)
Vanguard Growth Etf Etf (VUG)
Dimensional Us Real Estate Etf Etf (DFAR)
Dimensional International Small Cap Etf Etf (DFIS)
Dimensional Emerging Markets Value Etf Etf (DFEV)
Nvidia Corporation Stock (NVDA)

View all positions for Root Financial Partners

Top funds holding Vertex Pharmaceuticals Incorporated

Capital World Investors
BlackRock
Capital Research Global Investors
Vanguard Capital Management
State Street Corporation
Invesco
Jpmorgan Chase & Co
Geode Capital Management
Vanguard Portfolio Management
Capital Research and Management Company - Division 3
Loomis, Sayles and
Franklin Resources
Wellington Management Company
Morgan Stanley
Ubs Global Asset Management Americas

View all funds holding Vertex Pharmaceuticals Incorporated